Latest Breaking News On - Institutional perspectives - Page 1 : comparemela.com

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer

Dr Cobain on the Importance of Molecular Testing in Metastatic Breast Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesErin frances cobainBreast cancer clinical research teamRogel cancer centerUniversity of michiganInstitutional perspectives

Garmezy Highlights Ongoing and Future Research Directions Across RCC Subtypes

Benjamin Garmezy, MD, provides an overview of recent data on immuno-oncology/TKI combination data in variant renal cell carcinoma.

United statesBenjamin garmezyGenitourinary research at sarah cannon instituteInstitutional perspectivesGenitourinary researchSarah cannon research instituteTennessee oncologyGenitourinary cancersRenal cell carcinoma

Individualized Approach Best Informs Choice of Frontline Immunotherapy or Targeted Therapy Combinations Across RCC Histologies

Benjamin Garmezy, MD, discusses challenges associated with navigating the current frontline armamentarium in both clear cell and variant RCC, the impact of frontline IO doublets and IO/TKI regimens on patient outcomes, and the importance of ongoing combination studies for patients with variant RCC.

United statesBenjamin garmezyGenitourinary researchSarah cannon research instituteTennessee oncologyInstitutional perspectivesSarah cannon research institute at tennessee oncologyOnclive tvImmunotherapy in gu cancersGu cancers

Continued Investigations are Pertinent for FDA Approvals in the Treatment of Patients With EGFR-mutated NSCLC

Jason Porter, MD, highlights the implications of recent data to emerge following the use of EGFR TKIs in the adjuvant setting, the importance of the potential upcoming FDA approval of osimertinib with chemotherapy in EGFR-positive non–small cell lung cancer, and more.

United statesWadet iamsDanielv wakefieldErina gillaspieNagla abdel karimJason porterVanderbilt ingram cancer centerResearch institute in memphisUniversity of virginiaInstitutional perspectivesLung cancer disease research groupWest cancer centerResearch instituteEgfr tkisAdaura trialInstitutional perspectives in cancer

Sequencing BCMA-Directed Therapies Expands Multiple Myeloma Treatment Horizons

Sikander Ailawadhi, MD, spotlights the characteristics of multiple myeloma that drive the decision to use teclistamab-cqyv, elranatamab-bcmm, or talquetamab-tgvs.

United statesSikander ailawadhiNational cancer instituteMayo clinicInstitutional perspectivesAfrican americanOnclive institutional perspectives in cancerMultiple myeloma